Cargando…
Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease
Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for their clinical management. One of the common pathophy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952114/ https://www.ncbi.nlm.nih.gov/pubmed/36829822 http://dx.doi.org/10.3390/antiox12020262 |
_version_ | 1784893550049099776 |
---|---|
author | Infante-Menéndez, Jorge González-López, Paula Huertas-Lárez, Raquel Gómez-Hernández, Almudena Escribano, Óscar |
author_facet | Infante-Menéndez, Jorge González-López, Paula Huertas-Lárez, Raquel Gómez-Hernández, Almudena Escribano, Óscar |
author_sort | Infante-Menéndez, Jorge |
collection | PubMed |
description | Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for their clinical management. One of the common pathophysiological alterations that underlies both diseases is oxidative stress (OxS), which appears as a result of lipid deposition in affected tissues. However, the molecular mechanisms that lead to OxS generation are different in each disease. Non-coding RNAs (ncRNAs) are RNA transcripts that do not encode proteins and function by regulating gene expression. In recent years, the involvement of ncRNAs in OxS modulation has become more recognized. This review summarizes the most recent advances regarding ncRNA-mediated regulation of OxS in atherosclerosis and NAFLD. In both diseases, ncRNAs can exert pro-oxidant or antioxidant functions by regulating gene targets and even other ncRNAs, positioning them as potential therapeutic targets. Interestingly, both diseases have common altered ncRNAs, suggesting that the same molecule can be targeted simultaneously when both diseases coexist. Finally, since some ncRNAs have already been used as therapeutic agents, their roles as potential drugs for the clinical management of atherosclerosis and NAFLD are analyzed. |
format | Online Article Text |
id | pubmed-9952114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99521142023-02-25 Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease Infante-Menéndez, Jorge González-López, Paula Huertas-Lárez, Raquel Gómez-Hernández, Almudena Escribano, Óscar Antioxidants (Basel) Review Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for their clinical management. One of the common pathophysiological alterations that underlies both diseases is oxidative stress (OxS), which appears as a result of lipid deposition in affected tissues. However, the molecular mechanisms that lead to OxS generation are different in each disease. Non-coding RNAs (ncRNAs) are RNA transcripts that do not encode proteins and function by regulating gene expression. In recent years, the involvement of ncRNAs in OxS modulation has become more recognized. This review summarizes the most recent advances regarding ncRNA-mediated regulation of OxS in atherosclerosis and NAFLD. In both diseases, ncRNAs can exert pro-oxidant or antioxidant functions by regulating gene targets and even other ncRNAs, positioning them as potential therapeutic targets. Interestingly, both diseases have common altered ncRNAs, suggesting that the same molecule can be targeted simultaneously when both diseases coexist. Finally, since some ncRNAs have already been used as therapeutic agents, their roles as potential drugs for the clinical management of atherosclerosis and NAFLD are analyzed. MDPI 2023-01-24 /pmc/articles/PMC9952114/ /pubmed/36829822 http://dx.doi.org/10.3390/antiox12020262 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Infante-Menéndez, Jorge González-López, Paula Huertas-Lárez, Raquel Gómez-Hernández, Almudena Escribano, Óscar Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title | Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title_full | Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title_fullStr | Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title_full_unstemmed | Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title_short | Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease |
title_sort | oxidative stress modulation by ncrnas and their emerging role as therapeutic targets in atherosclerosis and non-alcoholic fatty liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952114/ https://www.ncbi.nlm.nih.gov/pubmed/36829822 http://dx.doi.org/10.3390/antiox12020262 |
work_keys_str_mv | AT infantemenendezjorge oxidativestressmodulationbyncrnasandtheiremergingroleastherapeutictargetsinatherosclerosisandnonalcoholicfattyliverdisease AT gonzalezlopezpaula oxidativestressmodulationbyncrnasandtheiremergingroleastherapeutictargetsinatherosclerosisandnonalcoholicfattyliverdisease AT huertaslarezraquel oxidativestressmodulationbyncrnasandtheiremergingroleastherapeutictargetsinatherosclerosisandnonalcoholicfattyliverdisease AT gomezhernandezalmudena oxidativestressmodulationbyncrnasandtheiremergingroleastherapeutictargetsinatherosclerosisandnonalcoholicfattyliverdisease AT escribanooscar oxidativestressmodulationbyncrnasandtheiremergingroleastherapeutictargetsinatherosclerosisandnonalcoholicfattyliverdisease |